Search within:  

Sort results by:      



1-20 of 1039   Next >
 
2.  
Recommendations for drug therapies for relapsing-remitting multiple sclerosis. 2013 Oct. NGC:010418
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
5.  
6.  
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. 2012 Sep. NGC:009487
European Heart Rhythm Association - Professional Association; Heart Rhythm Society - Professional Association. View all guidelines by the developer(s)
8.  
Dapagliflozin in combination therapy for treating type 2 diabetes. 2013 Jun. NGC:009946
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
9.  
Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes. 2010 Aug (revised 2013 Jul). NGC:009997
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by the developer(s)
10.  
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. 1998 Apr (revised 2013 Jan 22). NGC:009902
American College of Cardiology Foundation - Medical Specialty Society; American Heart Association - Professional Association; Heart Rhythm Society - Professional Association. View all guidelines by the developer(s)
13.  
Empagliflozin in combination therapy for treating type 2 diabetes. 2015 Mar. NGC:010695
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
14.  
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. 2011 Aug (revised 2013 Sep). NGC:010006
Clinical Pharmacogenetics Implementation Consortium - Independent Expert Panel. View all guidelines by the developer(s)
15.  
Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. 2008 (revised 2011). NGC:008788
World Health Organization - International Agency. View all guidelines by the developer(s)
17.  
Antithrombotic therapy supplement. 2001 Sep (revised 2013 Feb). NGC:009698
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
19.  
Antiretroviral therapy. 2003 Mar (revised 2014 Jan). NGC:010394
New York State Department of Health - State/Local Government Agency [U.S.]. View all guidelines by the developer(s)
1-20 of 1039   Next >